Two cases of Alzheimer&#39;s disease showing deterioration of behavioral and psychological symptoms of dementia induced by switching from rivastigmine to donepezil

Código QR

Two cases of Alzheimer&#39;s disease showing deterioration of behavioral and psychological symptoms of dementia induced by switching from rivastigmine to donepezil

Takemi Kimura, Junichi TakamatsuDivision of Clinical Research, National Hospital Organization Kikuchi Hospital, Koshi, Kumamoto, JapanAbstract: Rivastigmine, galantamine, and memantine, in addition to donepezil, which has been on the market over 10 years, have been available for the treatment of Alz...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Kimura T, Takamatsu J
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2012
Materias:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/f3a5d771b03c42fa919bc47881f74f4d
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Impact of Plasma Donepezil Concentration on Behavioral and Psychological Symptoms of Dementia in Patients with Alzheimer’s Disease
por: Yoshiyuki Kagawa, et al.
Publicado: (2021)

Rivastigmine in the treatment of Alzheimer's disease: an update
por: Maria Luisa Onor, et al.
Publicado: (2007)

Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer’s disease: A systematic review and meta-analysis
por: Richard A Hansen, et al.
Publicado: (2008)

Rivastigmine for the treatment of dementia associated with Parkinson&rsquo;s disease
por: Jennifer L Reingold, et al.
Publicado: (2007)

Domperidone effective in preventing rivastigmine-related gastrointestinal disturbances in patients with Alzheimer's disease
por: Kano O, et al.
Publicado: (2013)

Potential therapeutic effect of nanobased formulation of rivastigmine on rat model of Alzheimer&#39;s disease
por: Ismail MF, et al.
Publicado: (2013)

Rivastigmine in Chinese patients with subcortical vascular dementia
por: Vincent Mok, et al.
Publicado: (2007)

Clinically meaningful treatment responses after switching to galantamine and with addition of memantine in patients with Alzheimer&rsquo;s disease receiving donepezil
por: Kano O, et al.
Publicado: (2013)

Effectiveness and tolerability of transdermal rivastigmine in the treatment of Alzheimer&rsquo;s disease in daily practice
por: Seibert J, et al.
Publicado: (2012)

Management of the behavioral and psychological symptoms of dementia
por: Elizabeth C Hersch, et al.
Publicado: (2008)

Galantamine versus donepezil in Chinese patients with Alzheimer&rsquo;s disease: results from a randomized, double-blind study
por: Zhang Z, et al.
Publicado: (2012)

Rivastigmine: the advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and Parkinson’s disease dementia
por: Kandiah N, et al.
Publicado: (2017)

Treatment of behavioral and psychological symptoms of dementias with psychopharmaceuticals: a review
por: Masopust J, et al.
Publicado: (2018)

Cost-effectiveness analysis of memantine for moderate-to-severe Alzheimer&#39;s disease in the Netherlands
por: Hoogveldt B, et al.
Publicado: (2011)

Clinical efficacy and safety of donepezil in the treatment of Alzheimer’s disease in Chinese patients
por: Zhang N, et al.
Publicado: (2018)

Yokukansan improves behavioral and psychological symptoms of dementia by suppressing dopaminergic function
por: Takeyoshi K, et al.
Publicado: (2016)

Use of Methylphenidate in Excessive Daytime Sleepiness in Alzheimer’s Patients Treated with Donepezil: Case Series
por: Bidzan L, et al.
Publicado: (2020)

Could lysine supplementation prevent Alzheimer&rsquo;s dementia? A novel hypothesis
por: Robert N Rubey
Publicado: (2010)

Editor&#39;s choice
por: Pinder RM
Publicado: (2012)

Pain as a challenge in nursing home residents with behavioral and psychological symptoms of dementia
por: Nowak T, et al.
Publicado: (2018)

Serum homocysteine levels are correlated with behavioral and psychological symptoms of Alzheimer’s disease
por: Kim H, et al.
Publicado: (2014)

Precision Medicine of Sodium Benzoate for the Treatment of Behavioral and Psychological Symptoms of Dementia (BPSD)
por: Lin CH, et al.
Publicado: (2020)

Galantamine treatment in Alzheimer&#39;s disease: response and long-term outcome in a routine clinical setting
por: Wallin &Aring;K, et al.
Publicado: (2011)

Minimally invasive biomarker confirms glial activation present in Alzheimer&#39;s disease: a preliminary study
por: Tran T, et al.
Publicado: (2011)

Decreased white matter integrity before the onset of delusions in patients with Alzheimer&#39;s disease: diffusion tensor imaging
por: Nakaaki S, et al.
Publicado: (2012)

Plasma N-glycome shows continuous deterioration as the diagnosis of insulin resistance approaches
por: Gordan Lauc, et al.
Publicado: (2021)

Effectiveness and Safety of Aromatherapy in Managing Behavioral and Psychological Symptoms of Dementia: A Mixed-Methods Systematic Review
por: Becky Siu Yin Li, et al.
Publicado: (2021)

Review: management of Parkinson&#39;s disease
por: Pedrosa DJ, et al.
Publicado: (2013)

The genetics of Alzheimer's disease
por: Bagyinszky E, et al.
Publicado: (2014)

Demography, diagnostics, and medication in dementia with Lewy bodies and Parkinson's disease with dementia: data from the Swedish Dementia Quality Registry (SveDem)
por: Fereshtehnejad SM, et al.
Publicado: (2013)

Influence of rs1080985 single nucleotide polymorphism of the CYP2D6 gene on response to treatment with donepezil in patients with Alzheimer’s disease
por: Klimkowicz-Mrowiec A, et al.
Publicado: (2013)

Cilostazol add-on therapy in patients with mild dementia receiving donepezil: a retrospective study.
por: Masafumi Ihara, et al.
Publicado: (2014)

The effects of rivastigmine plus selegiline on brain acetylcholinesterase, (Na+,&nbsp;K+)-, Mg2+-ATPase activities, antioxidant status, and learning performance of aged rats
por: Haris Carageorgiou, et al.
Publicado: (2008)

Psychosocial therapy for Parkinson's-related dementia: intervention development
por: McCormick SA, et al.
Publicado: (2017)

Rehabilitating a brain with Alzheimer's: a proposal
por: Gonzalo Emiliano Aranda-Abreu, et al.
Publicado: (2011)

A non-pharmacological intervention to manage behavioral and psychological symptoms of dementia and reduce caregiver distress: Design and methods of project ACT3
por: Laura N Gitlin, et al.
Publicado: (2008)

Adjunctive therapy in Parkinson&#39;s disease: the role of rasagiline
por: Gaines KD, et al.
Publicado: (2012)

The Efficacy of Transdermal Rivastigmine in Mild to Moderate Alzheimer’s Disease with Concomitant Small Vessel Cerebrovascular Disease: Findings from an Open-Label Study
por: Yatawara C, et al.
Publicado: (2021)

Addenbrooke's cognitive examination III in the diagnosis of dementia: a critical review
por: Bruno D, et al.
Publicado: (2019)

Impact of cholinesterase inhibitors on behavioral and psychological symptoms of Alzheimer’s disease: A meta-analysis
por: Noll Campbell, et al.
Publicado: (2008)